sdz mks 492 has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 1 studies
| Studies (sdz mks 492) | Trials (sdz mks 492) | Recent Studies (post-2010) (sdz mks 492) | Studies (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Trials (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Recent Studies (post-2010) (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) |
|---|---|---|---|---|---|
| 8 | 2 | 0 | 449 | 1 | 24 |
| Protein | Taxonomy | sdz mks 492 (IC50) | 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (IC50) |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | 6 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | 6 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | 6 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 4.55 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | 6 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 4.8 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 4.8 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 4.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, J; Kurita, C; Nagai, H; Nagao, T; Nakao, T; Tanaka, H; Usami, E; Watanabe, S; Yamazaki, F; Yoshimura, T | 1 |
1 other study(ies) available for sdz mks 492 and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
| Article | Year |
|---|---|
Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aminophylline; Bucladesine; Cytokines; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Isoenzymes; Leukocytes, Mononuclear; Lipopolysaccharides; Milrinone; Naphthyridines; Phosphodiesterase Inhibitors; Purinones; Pyridones; Pyrrolidinones; Rolipram; Terbutaline; Tumor Necrosis Factor-alpha | 1997 |